We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · February 13, 2021

Preadmission Use of Inhaled Corticosteroids and Risk of Fatal or Severe COVID-19

The Journal of Asthma : Official Journal of the Association for the Care of Asthma

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Journal of Asthma : Official Journal of the Association for the Care of Asthma
Preadmission Use of Inhaled Corticosteroids and Risk of Fatal or Severe COVID-19: A Meta-Analysis
J Asthma 2021 Jan 18;[EPub Ahead of Print], CS Kow, SS Hasan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading